Analysts Set Expectations for Passage Bio, Inc.’s Q3 2024 Earnings (NASDAQ:PASG)

Passage Bio, Inc. (NASDAQ:PASG – Free Report) – Wedbush lifted their Q3 2024 earnings estimates for Passage Bio in a report issued on Thursday, August 8th. Wedbush analyst L. Chico now forecasts that the company will earn ($0.17) per share for the quarter, up from their previous estimate of ($0.18). The consensus estimate for Passage […]

Leave a Reply

Your email address will not be published.

Previous post Short Interest in The Crypto Company (OTCMKTS:CRCW) Expands By 38,209.9%
Next post Intellia Therapeutics, Inc. to Post Q3 2024 Earnings of ($1.36) Per Share, Wedbush Forecasts (NASDAQ:NTLA)